Vanguard DAPiThis page contains information on Vanguard DAPi for veterinary use.
The information provided typically includes the following:
- Vanguard DAPi Indications
- Warnings and cautions for Vanguard DAPi
- Direction and dosage information for Vanguard DAPi
Vanguard DAPiThis treatment applies to the following species:
Canine Distemper-Adenovirus Type 2-Parainfluenza Vaccine
Modified Live Virus
For use in dogs only
For vaccination of healthy dogs 6 weeks of age or older as an aid in preventing disease caused by canine distemper virus, canine adenovirus type 1, canine adenovirus type 2, and canine parainfluenza virus. Vaccination and revaccination according to label directions have been demonstrated (under field conditions) to result in serum antibody titers that persist for 12-48 months against CAV-1 (SN ≥ 1:16), CAV-2 (SN ≥ 1:16) and CPI virus (SN ≥ 1:16).
Directions For Use
Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well, and administer 1 mL subcutaneously or intramuscularly. Healthy dogs should receive 2 doses administered 3-4 weeks apart. If dogs are vaccinated before the age of 4 months, they should be revaccinated upon reaching 4 months of age. (Maternal antibodies may interfere with development of an adequate immune response in puppies less than 4 months old.) The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
PrecautionsStore at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Inactivate unused contents before disposal. Contains gentamicin as preservative. Vaccination of pregnant bitches should be avoided. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy. Do not mix with other products, except as specified above. In case of human exposure, contact a physician.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).
This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
VLN 190/PCN 13C1.20
Zoetis Inc., Kalamazoo, MI 49007, USA
25 1-dose vials of vaccine, rehydrate each to 1 mL
25 1-mL vials of sterile diluent
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Vanguard DAPi information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-05-30